Lesinurad
Drug Details
- Description
- Lesinurad is a selective uric acid reabsorption inhibitor (SURI) used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout. It works by inhibiting the function of the URAT1 transporter, reducing serum uric acid levels.
- Alternative Names
- Lesinurad.
- Key Genes
- The key gene associated with Lesinurad is SLC22A12, which encodes the URAT1 protein involved in uric acid reabsorption in the kidneys.
- Drug Use
- Lesinurad is used to treat hyperuricemia associated with gout. It works by inhibiting the function of proteins involved in uric acid reabsorption in the kidneys, thereby increasing uric acid excretion.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report